Journal article
SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race.
Abstract
SOURCE CITATION: Gupta K, Spertus JA, Birmingham M, et al. Racial differences in quality of life in patients with heart failure treated with sodium-glucose cotransporter 2 inhibitors: a patient-level meta-analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF trials. Circulation. 2023;148:220-228. 37191040.
Authors
Pandey A; Van Spall HGC
Journal
Annals of Internal Medicine, Vol. 176, No. 9,
Publisher
American College of Physicians
Publication Date
9 2023
DOI
10.7326/j23-0071
ISSN
1056-8751